NEJM January 29, 2025

Current preventive treatments for hereditary angioedema must be used regularly to reduce the risk of potentially life-threatening angioedema...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe?
On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval
The First Diagnostic Immunome
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity

Share This Article